Cost-Effectiveness of Once-Daily, Single-Inhaler Indacaterol Acetate/ Glycopyrronium Bromide/ Mometasone Furoate in Patients with Uncontrolled Moderate-to-Severe Asthma in Canada

• Main Authors: Mtibaa M (Author), Gupta S (Author), Muthukumar M (Author), Marvel J (Author), Kaur H (Author), Ishikawa R (Author), Olivenstein R (Author)
• Format: Book
• Published: Dove Medical Press, 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Mondher Mtibaa,1 Subhajit Gupta,2 Madhusubramanian Muthukumar,2 Jessica Marvel,3 Harneet Kaur,2 Ryotaro Ishikawa,3 Ron Olivenstein4 1Novartis Pharmaceuticals Canada Inc., Dorval, Quebec, Canada; 2Novartis Healthcare Private Limited, Hyderabad, India; 3Novartis Pharma AG, Basel, Switzerland; 4McGill...